Anticoagulant and antithrombotic properties of platelet protease nexin-1

Blood

Volumn 115, Issue 1, 2010, Pages 97-106

  Boulaftali, Yacine ^a   Adam, Frédéric ^a   Venisse, Laurence ^a   Ollivier, Véronique ^a   Richard, Benjamin ^a   Taieb, Sabrina ^b   Monard, Denis ^b   Favier, Rémi ^a,c   Alessi, Marie Christine ^d,e   Bryckaert, Marijke ^a   Arocas, Véronique ^a   Jandrot Perrus, Martine ^a   Bouton, Marie Christine ^a  

^a INSERM   (France)

^b FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH   (Switzerland)

^c ARMAND TROUSSEAU HOSPITAL   (France)

^d CNRS   (France)

^e AIX MARSEILLE UNIVERSITY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; FERRIC CHLORIDE; GLYCOSAMINOGLYCAN; PADGEM PROTEIN; PROTEASE NEXIN I; THROMBIN; THROMBOPLASTIN; UROKINASE; AMYLOID PRECURSOR PROTEIN; ANTICOAGULANT AGENT; ANTITHROMBIN; CELL SURFACE RECEPTOR; PROTEASE NEXINS;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTICOAGULATION; ARTERY THROMBOSIS; ARTICLE; AUTOANALYSIS; AUTOMATED THROMBOGRAPHY; BLEEDING DISORDER; BLOOD FLOW; BLOOD VESSEL INJURY; CALIBRATION; CASE REPORT; CELL SURFACE; CONTROLLED STUDY; ENZYME BINDING; ENZYME INHIBITION; ENZYME RELEASE; GRAY PLATELET SYNDROME; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOGENESIS; THROMBOSIS; THROMBUS; VEIN THROMBOSIS; ADULT; ANIMAL; BLOOD VESSEL; CELL MEMBRANE; CIRCULATION; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; SECRETION; THROMBOCYTE RICH PLASMA; TIME;

ADULT; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; ANTICOAGULANTS; ANTITHROMBINS; BLOOD CIRCULATION; BLOOD PLATELETS; BLOOD VESSELS; CELL MEMBRANE; COLLAGEN; GLYCOSAMINOGLYCANS; HUMANS; MICE; PLATELET AGGREGATION; PLATELET-RICH PLASMA; RECEPTORS, CELL SURFACE; THROMBIN; THROMBOPLASTIN; THROMBOSIS; TIME FACTORS; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 74949101214     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2009-04-217240     Document Type: Article

References (40)

1. Mann KG, Nesheim ME, Church WR, Haley P, Krishnaswamy S. Surface-dependent reactions of the vitamin K-dependent enzyme complexes. Blood. 1990;76(1):1-16.
2. Potter van Loon BJRD, Brommer EJ, van der Maas AP. The amount of plasminogen activator and plasminogen activator type 1 in human thrombi and the relation to ex-vivo lysibility. Thromb Haemost. 1992;67(2):101-105.
3. Booth NA, Simpson AJ, Croll A, Bennett B, MacGregor IR. Plasminogen activator inhibitor (PAI-1) in plasma and platelets. Br J Haematol. 1988;70(3):327-333.
4. Declerck PJ, Alessi MC, Verstreken M, Kruithof EK, Juhan-Vague I, Collen D. Measurement of plasminogen activator inhibitor 1 in biologic fluids with a murine monoclonal antibody-based enzyme-linked immunosorbent assay. Blood. 1988;71(1):220-225.
5. Fay WP, Eitzman DT, Shapiro AD, Madison EL, Ginsburg D. Platelets inhibit fibrinolysis in vitro by both plasminogen activator inhibitor-1-dependent and -independent mechanisms. Blood. 1994; 83(2):351-356.
6. Gronke RS, Bergman BL, Baker JB. Thrombin interaction with platelets: influence of a platelet protease nexin. J Biol Chem. 1987;262(7):3030-3036.
7. Gronke RS, Knauer DJ, Veeraraghavan S, Baker JB. A form of protease nexin I is expressed on the platelet surface during platelet activation. Blood. 1989;73(2):472-478.
8. Evans DL, McGrogan M, Scott RW, Carrell RW. Protease specificity and heparin binding and activation of recombinant protease nexin I. J Biol Chem. 1991;266(33):22307-22312.
9. Stone SR, Nick H, Hofsteenge J, Monard D. Glial-derived neurite-promoting factor is a slow-binding inhibitor of trypsin, thrombin, and urokinase. Arch Biochem Biophys. 1987;252(1):237-244.
10. Baker JB, Gronke RS. Protease nexins and cellular regulation. Semin Thromb Hemost. 1986; 12(3):216-220.
11. Mansuy IM, van der Putten H, Schmid P, Meins M, Botteri FM, Monard D. Variable and multiple expression of Protease Nexin-1 during mouse organogenesis and nervous system development. Development. 1993;119(4):1119-1134.
12. Pratt CW, Church FC. General features of the heparin-binding serpins antithrombin, heparin cofactor II and protein C inhibitor. Blood Coagul Fibrinolysis. 1993;4(3):479-490.
13. Rovelli G, Stone SR, Preissner KT, Monard D. Specific interaction of vitronectin with the cell-secreted protease inhibitor glia-derived nexin and its thrombin complex. Eur J Biochem. 1990; 192(3):797-803.
14. van Meijer M, Smilde A, Tans G, Nesheim ME, Pannekoek H, Horrevoets AJ. The suicide substrate reaction between plasminogen activator inhibitor 1 and thrombin is regulated by the cofactors vitronectin and heparin. Blood. 1997;90(5): 1874-1882.
15. Benit L, Cramer E, Masse J, Dusanter-Four I, Favier R. Molecular study of the hematopoietic zinc finger gene in three unrelated families with gray platelet syndrome. J Thromb Haemost. 2006;3(21):2077-2080.
16. Luthi A, Van der Putten H, Botteri FM, et al. Endogenous serine protease inhibitor modulates epileptic activity and hippocampal long-term potentiation. J Neurosci. 1997;17(12):4688-4699.
17. Carmeliet P, Kieckens L, Schoonjans L, et al. Plasminogen activator inhibitor-1 gene-deficient mice: I. Generation by homologous recombination and characterization. J Clin Invest. 1993; 92(6):2746-2755.
18. Jandrot-Perrus M, Lagrue AH, Okuma M, Bon C. Adhesion and activation of human platelets induced by convulxin involve glycoprotein VI and integrin alpha2beta1. J Biol Chem. 1997;272(43): 27035-27041.
19. Akaaboune M, Hantai D, Smirnova I, et al. Developmental regulation of the serpin, protease nexin I, localization during activity-dependent polyneuronal synapse elimination in mouse skeletal muscle. J Comp Neurol. 1998;397(4):572-579.
20. Mbebi C, Hantai D, Jandrot-Perrus M, Doyennette MA, Verdiere-Sahuque M. Protease nexin I expression is up-regulated in human skeletal muscle by injury-related factors. J Cell Physiol. 1999;179(3):305-314.
21. Mansilla S, Boulaftali Y, Venisse L, et al. Macrophages and platelets are the major source of protease nexin-1 in human atherosclerotic plaque. Arterioscler Thromb Vasc Biol. 2008;28(10):1844-1850.
22. Bouton MC, Venisse L, Richard B, Pouzet C, Arocas V, Jandrot-Perrus M. Protease nexin-1 interacts with thrombomodulin and modulates its anticoagulant effect. Circ Res. 2007;100(8):1174-1181.
23. Bezeaud A, Denninger MH, Guillin MC. Interaction of human alpha-thrombin and gamma-thrombin with antithrombin III, protein C and thrombomodulin. Eur J Biochem. 1985;153(3): 491-496.
24. Naessens D, Gils A, Compernolle G, Declerck PJ. Elucidation of the epitope of a latency-inducing antibody: identification of a new molecular target for PAI-1 inhibition. Thromb Haemost. 2003;90(1):52-58.
25. Verbeke K, Gils A, Declerck PJ. Inhibition of plasminogen activator inhibitor-1: antibody fragments and their unique sequences as a tool for the development of profibrinolytic drugs. J Thromb Haemost. 2004;2(2):298-305.
26. Hemker HC, Giesen PL, Ramjee M, Wagenvoord R, Beguin S. The thrombogram: monitoring thrombin generation in platelet-rich plasma. Thromb Haemost. 2000;83(4):589-591.
27. Leon C, Ravanat C, Freund M, Cazenave JP, Gachet C. Differential involvement of the P2Y1 and P2Y12 receptors in platelet procoagulant activity. Arterioscler Thromb Vasc Biol. 2003;23(10): 1941-1947.
28. Munnix IC, Kuijpers MJ, Auger J, et al. Segregation of platelet aggregatory and procoagulant microdomains in thrombus formation: regulation by transient integrin activation. Arterioscler Thromb Vasc Biol. 2007;27(11):2484-2490.
29. Kauskot A, Cominetti MR, Ramos OH, et al. Hemostatic effects of recombinant DisBa-01, a disintegrin from Bothrops alternatus. Front Biosci. 2008;13:6604-6616.
30. Sommer J, Gloor SM, Rovelli GF, et al. cDNA sequence coding for a rat glia-derived nexin and its homology to members of the serpin superfamily. Biochemistry. 1987;26(20):6407-6410.
31. Richard B, Arocas V, Guillin MC, Michel JB, Jandrot-Perrus M, Bouton MC. Protease nexin-1: a cellular serpin down-regulated by thrombin in rat aortic smooth muscle cells. J Cell Physiol. 2004;201(1):138-145.
32. Racuglia G. Gray platelet syndrome: a variety of qualitative platelet disorder. Am J Med. 1971;51: 818-828.
33. Kanse SM, Chavakis T, Al-Fakhri N, Hersemeyer K, Monard D, Preissner KT. Reciprocal regulation of urokinase receptor (CD87)-mediated cell adhesion by plasminogen activator inhibitor-1 and protease nexin-1. J Cell Sci. 2004;117(3):477-485.
34. Battinelli E, Hartwig J, Italiano J. Delivering new insight into the biology of megakaryopoiesis and thrombopoiesis. Curr Opin Hematol. 2007;14(5): 419-426.
35. Brogren H, Karlsson L, Andersson M, Wang L, Erlinge D, Jern S. Platelets synthesize large amounts of active plasminogen activator inhibitor 1. Blood. 2004;104(13):3943-3948.
36. Levi M, Biemond BJ, van Zonneveld AJ, ten Cate JW, Pannekoek H. Inhibition of plasminogen activator inhibitor-1 activity results in promotion of endogenous thrombolysis and inhibition of thrombus extension in models of experimental thrombosis. Circulation. 1992;85(1):305-312.
37. Lijnen HR, van Hoef B, Beelen V, Collen D. Characterization of the murine plasma fibrinolytic system. Eur J Biochem. 1994;224(3):863-871.
38. Eaton DL, Scott RW, Baker JB. Purification of human fibroblast urokinase proenzyme and analysis of its regulation by proteases and protease nexin. J Biol Chem. 1984;259(10):6241-6247.
39. Monroe DM, Hoffman M, Roberts HR. Platelets and thrombin generation. Arterioscler Thromb Vasc Biol. 2002;22(9):1381-1389.
40. Hemker HC, Beguin S. Thrombin generation in plasma: its assessment via the endogenous thrombin potential. Thromb Haemost. 1995;74(1): 134-138.